Sec Form 4 Filing - YOUNG TODD S. @ Elanco Animal Health Inc - 2020-08-03

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person YOUNG TODD S. 2. Issuer Name and Ticker or Trading Symbol Elanco Animal Health Inc [ ELAN] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) See Remarks (Last) (First) (Middle) C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY 3. Date of Earliest Transaction (MM/DD/YY) 08/03/2020 (Street) GREENFIELD, IN46140 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 41,513 D Common Stock 08/03/2020 P 2,000 A $ 23.85 2,000 I by J. G. Young IRA Common Stock 08/03/2020 P 5,000 A $ 23.94 5,000 I by IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisabl e Expiration Date Title Amount or Number of Shares Tangible Equity Units ( 1 ) 08/03/2020 P 1,000 ( 1 ) ( 1 ) Common Stock 1,562 ( 2 ) $ 40.55 1,000 I by IRA

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other YOUNG TODD S. C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD, IN46140 See Remarks Signatures /s/ Darlene Quashie Henry, as Attorney-in-Fact for Todd S. Young 08/04/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Each 5.00% Tangible Equity Unit (TEU) includes a prepaid stock purchase contract that will automatically settle on February 1, 2023 (unless settled early at the holder's discretion) for between 1.3021 and 1.5625 shares of Elanco's common stock (subject to adjustment in certain circumstances), based upon the applicable market value of Elanco's common stock prior to settlement. The Reporting Person may elect to settle the purchase contracts prior to February 1, 2023 at the minimum settlement rate of 1.3021 shares of Elanco's common stock. Additionally the purchase contracts may be settled early by the Reporting Person or Elanco under certain circumstances described in the purchase contract. ( 2 )Represents the maximum number of shares of Elanco's common stock initially issuable upon settlement of the purchase contract included in the TEUs based on the maximum settlement rate.

Remarks: Executive Vice President and Chief Financial Officer

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.